NCNMGF
HBIO icon

Nano-Cap New Millennium Growth Fund’s Harvard Bioscience HBIO Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880K Buy
143,082
+25,582
+22% +$153K 0.68% 54
2026
Q1 		$572K Buy
117,500
+57,500
+96% +$321K 0.54% 70
2025
Q4 		$401K Buy
+60,000
New +$356K 0.34% 86

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's HBIO Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Harvard Bioscience (HBIO) stake by 22% in Q2 2026, buying an estimated $153K and bringing the position to 143,082 shares worth $880K. The position accounts for 0.68% of the portfolio, ranked #54.

Nano-Cap New Millennium Growth Fund first reported a position in HBIO in Q4 2025 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 143,082 shares of Harvard Bioscience worth $880K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 25,582 Harvard Bioscience shares in Q2 2026, an estimated $153K.
  • Harvard Bioscience made up 0.68% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #54 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Harvard Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.